Literature DB >> 1531413

What are minor histocompatibility loci? A new look at an old question.

D C Roopenian1.   

Abstract

In this article, Derry Roopenian relates the traditional view of minor histocompatibility (H) loci to recent advances in understanding of the tissue rejection process and the molecular nature of minor histocompatibility antigens. He proposes that minor H loci can be subdivided by the ability of their products to stimulate different T-cell subsets and discusses the implications of this concept in terms of the origins and behavior of minor H loci and their antigens, tumor immunology and autoimmunity.

Entities:  

Mesh:

Year:  1992        PMID: 1531413     DOI: 10.1016/0167-5699(92)90197-F

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  19 in total

1.  A single nucleotide polymorphism in the Emp3 gene defines the H4 minor histocompatibility antigen.

Authors:  Brianna Luedtke; Laura M Pooler; Eun Young Choi; Angela M Tranchita; Corbett J A Reinbold; Aaron C Brown; Daniel J Shaffer; Derry C Roopenian; Subramaniam Malarkannan
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

2.  Sensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade.

Authors:  H Xu; Y Huang; L R Hussain; Z Zhu; L D Bozulic; C Ding; J Yan; S T Ildstad
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

3.  Mixed chimerism renders residual host dendritic cells incapable of alloimmunization of the marrow donor in the canine model of allogeneic marrow transplantation.

Authors:  Steven L Rosinski; Scott S Graves; Deborah A Higginbotham; Rainer Storb
Journal:  Chimerism       Date:  2015-10-02

4.  The genetic origin of minor histocompatibility antigens.

Authors:  D C Roopenian; G J Christianson; A P Davis; A R Zuberi; L E Mobraaten
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. V. Chromosomal mapping of the immunodominant cytotoxic T-cell target-1 (CTT-1).

Authors:  M Vagliani; C Melani; G Parmiani; P D'Eustachio; P J Wettstein; M P Colombo
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Molecular polymorphism in the Rt6 genes of laboratory mice correlates with the allotypes of the H1 minor histocompatibility system.

Authors:  F Koch-Nolte; C Hollmann; M Kühl; F Haag; M Prochazka; E Leiter; H G Thiele
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

7.  Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR.

Authors:  I Miconnet; V de la Selle; C Tucek; R Huchet; D Bonardelle; M Bruley-Rosset
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 8.  Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.

Authors:  Seema R Patel; James C Zimring
Journal:  Transfus Med Rev       Date:  2013-10-03

9.  Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.

Authors:  S Pion; P Fontaine; C Baron; M Gyger; C Perreault
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 10.  H-Y antigens.

Authors:  U Müller
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.